ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Tubize-Fin (TUB.BR)
Tubize-Fin stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Euronext Brussels · Belgium
€218.80▼ -0.82%
Prices as of Oct 26, 2026 · EUR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Tubize-Fin in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Tubize-Fin
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Tubize-Fin a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €204.57 and €233.82; in 9 out of 10, between €181.72 and €263.22. Estimated annual volatility is 40%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- €7.7B
- Market cap (USD)
- $8.7B
- P/E ratio
- 88.9
- Dividend yield
- 0.62%
- 52-week high
- €250.50
- 52-week low
- €168.10
- Revenue (12 months)
- €0.0M
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- 0.40
What this means
ATLAS does not publish a fair value for TUB.BR right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks TUB.BR has traded between €168.10 and €250.50. Today it is 12.7% below that high and 30% above its low.
On the business: net margin is 0.0%; it trades at 88.9 times earnings.
Its beta is 0.40: it tends to move less than the market.
About the company
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Want to see everything about Tubize-Fin?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Tubize-Fin do?
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
What is the chance TUB.BR goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, TUB.BR ends the month between €204.57 and €233.82.
How big is Tubize-Fin and what is its P/E ratio?
Tubize-Fin's market capitalization is €7.7B. Its price-to-earnings (P/E) ratio is 88.9: you pay €88.9 for each €1.00 of yearly earnings.
Does Tubize-Fin pay a dividend?
Yes. TUB.BR's current dividend yield is 0.62% at today's price (€218.80).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer